tradingkey.logo
tradingkey.logo
Search

XORTX Therapeutics Inc

XRTX
Add to Watchlist
2.120USD
+0.100+4.95%
Close 07-31 16:00ETQuotes delayed by 15 min
2.95MMarket Cap
LossP/E TTM

XRTX Financials

See XORTX Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

XORTX Therapeutics Inc Earnings Date

Latest Release
May 19, 2026
EPS / Forecast
-2.90/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.81
51.26%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-1452.77%-2.90
-1306.15%-0.45
33.85%-0.13
-423.46%-0.19
84.96%-0.19
-97.23%0.04
96.65%-0.20
106.92%0.06
-30.88%-1.24
177.48%1.35
---6.03
---0.85
---0.95
---1.74
---2.60
----
----
----
----
----
Net Profit
-15.72%-808.47K
-581.87%-590.46K
-10.64%-649.47K
-522.01%-717.70K
76.86%-698.67K
-95.46%122.53K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
204.65%2.70M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-135.75%-2.58M
81.96%-1.20M
-596.98%-1.24M
-57.52%-2.70M
2176.87%7.21M
-1981.22%-6.64M
34.05%-177.75K
Debt to assets ratio
56.81%0.70%
46.69%1.39%
31.68%2.10%
68.27%2.93%
92.97%0.45%
350.00%0.95%
271.79%1.60%
201.12%1.74%
-63.59%0.23%
-66.43%0.21%
--0.43%
--0.58%
--0.64%
--0.63%
--0.85%
----
----
----
----
----
Operating profit
14.55%-823.30K
-3.80%-686.42K
18.13%-716.20K
40.42%-889.95K
11.50%-963.46K
32.78%-661.26K
37.30%-874.75K
15.21%-1.49M
42.92%-1.09M
63.02%-983.67K
33.66%-1.40M
33.56%-1.76M
33.68%-1.91M
-108.41%-2.66M
-553.96%-2.10M
-276.54%-2.65M
-372.68%-2.88M
-249.55%-1.28M
-12.23%-321.61K
-163.27%-704.20K
Net Profit
-15.72%-808.47K
-581.87%-590.46K
-10.64%-649.47K
-522.01%-717.70K
76.86%-698.67K
-95.46%122.53K
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
204.65%2.70M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-135.75%-2.58M
81.96%-1.20M
-596.98%-1.24M
-57.52%-2.70M
2176.87%7.21M
-1981.22%-6.64M
34.05%-177.75K
Current assets
-64.61%744.42K
-52.89%1.26M
-43.68%1.36M
-62.33%1.26M
-54.89%2.10M
-34.21%2.68M
-53.88%2.41M
-47.37%3.36M
-43.23%4.66M
-62.66%4.07M
-44.20%5.23M
-41.41%6.38M
-38.08%8.21M
-31.76%10.90M
56.48%9.37M
90.12%10.89M
107.78%13.27M
888.58%15.97M
232.81%5.99M
198.26%5.73M
Total current liabilities
13.68%860.99K
-20.97%599.07K
-51.22%837.41K
-66.03%711.46K
122.14%757.35K
157.00%757.99K
210.02%1.72M
419.43%2.09M
-43.16%340.93K
-80.48%294.94K
-60.61%553.76K
-47.83%403.26K
-12.41%599.79K
172.38%1.51M
-85.24%1.41M
-76.13%772.93K
-82.00%684.73K
-31.70%554.85K
1175.22%9.52M
404.67%3.24M
Total assets
-38.70%2.14M
-34.46%2.68M
-26.99%2.81M
-42.87%2.74M
-42.18%3.50M
-25.12%4.09M
-42.01%3.85M
-38.48%4.80M
-37.36%6.05M
-55.81%5.47M
-38.64%6.64M
-37.42%7.80M
-34.54%9.66M
-29.06%12.37M
75.14%10.82M
110.68%12.47M
124.65%14.75M
869.38%17.44M
208.83%6.18M
179.31%5.92M
Total liabilities
13.68%860.99K
-20.97%599.07K
-51.22%837.41K
-66.03%711.46K
-78.72%757.35K
-8.23%757.99K
210.02%1.72M
419.43%2.09M
493.46%3.56M
-84.64%825.94K
-82.00%553.76K
-86.34%403.26K
-85.13%599.79K
28.22%5.38M
-67.69%3.08M
-8.80%2.95M
6.03%4.03M
416.20%4.19M
1175.22%9.52M
404.67%3.24M
Total equity
-53.17%1.28M
-37.53%2.08M
-7.49%1.97M
-24.93%2.03M
10.04%2.74M
-28.12%3.34M
-64.95%2.13M
-63.44%2.70M
-72.50%2.49M
-33.66%4.64M
-21.40%6.09M
-22.23%7.40M
-15.50%9.06M
-47.19%7.00M
331.60%7.74M
255.09%9.51M
287.88%10.72M
1242.47%13.25M
-366.67%-3.34M
81.40%2.68M
Net operating income
22.12%-501.36K
20.82%-701.86K
16.26%-629.62K
-7.74%-793.52K
50.63%-643.73K
31.71%-886.41K
29.78%-751.85K
57.44%-736.54K
47.51%-1.30M
53.91%-1.30M
-10.66%-1.07M
7.88%-1.73M
0.79%-2.48M
10.21%-2.82M
-1476.71%-967.56K
-167.84%-1.88M
-171.05%-2.50M
-360.14%-3.14M
31.65%-61.37K
-401.41%-701.38K
Net investment
-133.83%-7.92K
-6447.50%-264.26K
76.33%-5.49K
-140.26%-21.82K
-29.05%-3.38K
58.80%-4.04K
-217.59%-23.18K
4.76%-9.08K
86.71%-2.62K
41.75%-9.79K
-56.50%-7.30K
55.81%-9.54K
-647.39%-19.73K
-24.49%-16.82K
52.35%-4.66K
-158.14%-21.58K
-1697.31%-2.64K
-519.83%-13.51K
-180.25%-9.79K
-221.40%-8.36K
Net financing
-254.19%-104.20K
-42.86%632.53K
3566.49%770.88K
-390.50%-43.44K
-96.03%67.58K
454.53%1.11M
-33.38%-22.24K
-1.08%-8.86K
7393.92%1.70M
-107.13%-312.25K
96.38%-16.67K
-41.46%-8.76K
---23.36K
-68.45%4.38M
-845.83%-460.78K
66.86%-6.19K
-100.00%0.00
1240.48%13.88M
---48.72K
---18.69K

FAQs

What are the current assets of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its current assets were 1.26M, with a year-on-year change of -52.89.

What are the total assets of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its total assets of XORTX Therapeutics Inc were 2.68M, with a year-on-year change of -34.46.

What are the total liabilities of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its total liabilities of XORTX Therapeutics Inc were 599.07K, with a year-on-year change of -20.97.

What is the total equity of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its total equity of XORTX Therapeutics Inc was 2.08M, with a year-on-year change of -37.53.

What is the net operating income of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its net operating income of XORTX Therapeutics Inc was -3.26M, with a year-on-year change of 20.94.

What is the net investment of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its net investment of XORTX Therapeutics Inc was -294.95K, with a year-on-year change of -657.77.

What is the net financing of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its net financing of XORTX Therapeutics Inc was 1.43M, with a year-on-year change of -48.64.

What is the Earnings Per Share (EPS) of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.81, with a year-on-year change of 51.26.

What is the net income of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its net income was -2.66M, with a year-on-year change of 19.83.

What is the debt-to-asset ratio of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 1.39, with a year-on-year change of 46.69.

What is the Return on Equity (ROE) of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -98.00, with a year-on-year change of -17.99.

What is the Return on Assets (ROA) of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -78.38, with a year-on-year change of -13.10.

What is the operating profit of XORTX Therapeutics Inc?

According to XORTX Therapeutics Inc's FY2025 earnings report, its operating profit was -3.26M, with a year-on-year change of 20.94.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.